Hosted on MSN2mon
Why Arcturus Therapeutics (ARCT) Is the Worst ARK Stock to Buy According to Short Sellers
In this article, we are going to take a look at where Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) stands against other worst ARK stocks to buy according to short sellers. Cathie Wood of ARK ...
Business Insider24d
Arcturus Therapeutics: Anticipated Growth through Innovative Therapies and Strategic Trials
Wells Fargo analyst Yanan Zhu has maintained their bullish stance on ARCT stock, giving a Buy rating on January 15. Discover outperforming stocks and invest smarter with Top Smart Score Stocks ...
Business Insider27d
Buy Rating for Arcturus Therapeutics Driven by Promising Vaccine Candidate and Strategic Partnerships
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a price target of $63.00. Discover outperforming stocks ...
Yahoo Finance3d
Arcturus Therapeutics Holdings Inc. (ARCT)
SAN DIEGO, January 30, 2025--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious ...